CHICAGO — Circulating tumor DNA (ctDNA), or DNA shed from tumors that is detected in the bloodstream, has shown increasing promise as a prognostic tool in […]

In patients with inflammatory bowel disease (IBD) and a history of cancer, immunosuppressive therapies don’t appear to increase the risk for incident cancer, according to an […]

VIENNA — The interleukin 1 receptor antagonist (IL-1RA) canakinumab provided control of systemic juvenile idiopathic arthritis (sJIA) without the use of glucocorticoids for up to a […]

SAN DIEGO — Researchers are unraveling the complex relationship between cardiovascular (CV)- and stroke-related outcomes in migraine with, and without, aura. Early results of one study […]

The capital of Spain recently hosted the European Hematology Association Congress 2024. In one of its first sessions, researchers discussed CAR-T therapy. Claire Roddie, MD, PhD, […]

VIENNA — The use of immunosuppressive and antifibrotic drugs to treat skin and lung fibrosis leads updated recommendations from the European Alliance of Associations for Rheumatology […]

VIENNA (Reuters) – The Taliban-ordered crash in opium production in Afghanistan, long the world’s dominant supplier, could drive up overdose deaths as heroin users switch to […]

MONTREAL —Tirzepatide (Mounjaro, Eli Lilly), the dual gastric inhibitory polypeptide–glucagon-like peptide 1 (GIP–GLP-1) receptor agonist that has shown significant benefits in diabetes and obesity, may also […]